Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.”

The report features an extensive study of the current market landscape and future opportunities for players offering services for repurposing / repositioning / reprofiling of drug candidates. It features an in-depth analysis, highlighting the capabilities of various service providers engaged in this domain. In addition to other elements, the study includes:
 A detailed assessment of the current market landscape of companies offering drug repurposing services.
 Elaborate profiles of key players that specialize in offering services for the development of repurposed drugs.
 An analysis of the partnerships that have been established in this domain, in the recent past.
 An analysis of the initiatives of big biopharma players engaged in this domain.
 A detailed analysis of more than 1,700 terminated / withdrawn / suspended clinical studies of the drug candidates.
 A detailed analysis on the cost saving potential of drug repurposing approaches, as compared to the traditional de novo drug development methods.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market s